DEV ENVIRONMENT — dev.library.globalcastmd.com — Changes here do not affect production
Playing from staycurrent-espanol
17 views 0 likes

StayCurrent Espanol

GCMD Space · View profile →

Manejo expectante o ibuprofeno temprano para el tratamiento del conducto arterioso persistente

Video Published 2023-08-30 Updated 2023-09-04

Timestops (7)

Topic Overview

Multicenter non-inferiority trial comparing expectant management versus early ibuprofen for patent ductus arteriosus in extremely premature infants (n=273). Expectant management showed non-inferior outcomes with lower rates of bronchopulmonary dysplasia (33.3% vs 50.9%) and similar necrotizing enterocolitis and mortality rates compared to ibuprofen treatment.

Key Takeaways

  • Expectant management was non-inferior to ibuprofen for PDA in extremely preterm infants (273 patients, multicenter trial).
  • Expectant management group: 17.6% NEC, 33.3% BPD, 14% mortality vs ibuprofen: 15.4% NEC, 50.9% BPD, 18.6% mortality.
  • Ibuprofen treatment associated with significantly higher BPD rates (50.9% vs 33.3%) compared to expectant management.
  • Conservative approach may avoid pharmacologic intervention without worsening outcomes in extremely preterm PDA patients.

Keywords

Hashtags

Transcript

Comments

Loading comments…